A Study of Adjuvant Melanoma Stakeholder Treatment Preferences
NCT05115006
·
clinicaltrials.gov ↗
COMPLETED
Status
294
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Sponsor
Bristol-Myers Squibb